Catalyst Pharmaceuticals Inc (CPRX)
15.12
+0.39
(+2.65%)
USD |
NASDAQ |
Apr 24, 16:00
15.12
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Cash and Short Term Investments (Quarterly): 137.64M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 137.64M |
September 30, 2023 | 120.97M |
June 30, 2023 | 178.79M |
March 31, 2023 | 148.25M |
December 31, 2022 | 298.40M |
September 30, 2022 | 256.06M |
June 30, 2022 | 220.79M |
March 31, 2022 | 197.80M |
December 31, 2021 | 191.27M |
September 30, 2021 | 174.79M |
June 30, 2021 | 155.28M |
March 31, 2021 | 143.30M |
December 31, 2020 | 140.28M |
September 30, 2020 | 127.11M |
June 30, 2020 | 115.05M |
March 31, 2020 | 101.75M |
December 31, 2019 | 94.52M |
September 30, 2019 | 76.54M |
June 30, 2019 | 59.92M |
March 31, 2019 | 45.63M |
December 31, 2018 | 53.48M |
September 30, 2018 | 61.66M |
June 30, 2018 | 68.41M |
March 31, 2018 | 77.94M |
December 31, 2017 | 84.01M |
Date | Value |
---|---|
September 30, 2017 | 33.91M |
June 30, 2017 | 35.13M |
March 31, 2017 | 36.53M |
December 31, 2016 | 40.41M |
September 30, 2016 | 44.74M |
June 30, 2016 | 48.02M |
March 31, 2016 | 52.45M |
December 31, 2015 | 58.40M |
September 30, 2015 | 62.96M |
June 30, 2015 | 67.40M |
March 31, 2015 | 71.54M |
December 31, 2014 | 39.28M |
September 30, 2014 | 41.45M |
June 30, 2014 | 45.01M |
March 31, 2014 | 21.28M |
December 31, 2013 | 23.71M |
September 30, 2013 | 27.65M |
June 30, 2013 | 11.37M |
March 31, 2013 | 13.16M |
December 31, 2012 | 15.42M |
September 30, 2012 | 11.97M |
June 30, 2012 | 7.515M |
March 31, 2012 | 4.723M |
December 31, 2011 | 6.029M |
September 30, 2011 | 2.151M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
59.92M
Minimum
Jun 2019
298.40M
Maximum
Dec 2022
154.66M
Average
143.30M
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Pfizer Inc | 12.69B |
Sarepta Therapeutics Inc | 1.676B |
PTC Therapeutics Inc | 876.74M |
Corcept Therapeutics Inc | 368.22M |
Cytokinetics Inc | 614.82M |